Vyvanse - 2007 FDA approvals

Drug: Vyvanse (lisdexamfetamine dimesylate)
Indication: ADHD
Company: New River Pharmaceuticals
Approval Date: 23-Feb-2007

Scoop: Vyvanse is amphetamine based, but only becomes effective after it enters the digestive tract. The company says that the digestive trigger mechanism should make the drug less liable for abuse by users who snort or inject pills.

More news:
FDA hands out two key regulatory approvals. Report